Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD

BACKGROUND: Inpatient admissions for chronic obstructive pulmonary disease (COPD) represent a significant economic burden, accounting for over half of direct medical costs. Reducing 30-day readmissions could save health care resources while improving patient care. Recently, the Patient Protection an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bollu, Vamsi, Ernst, Frank R, Karafilidis, John, Rajagopalan, Krithika, Robinson, Scott B, Braman, Sidney S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858026/
https://www.ncbi.nlm.nih.gov/pubmed/24353413
http://dx.doi.org/10.2147/COPD.S52557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858026/
https://www.ncbi.nlm.nih.gov/pubmed/24353413
http://dx.doi.org/10.2147/COPD.S52557

Ejemplares similares